NEW YORK (GenomeWeb) – Interpace Diagnostics today said that it plans to raise about $10.5 million in a public offering of its stock.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.